Pro Share Advisors LLC Mirum Pharmaceuticals, Inc. Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,457 shares of MIRM stock, worth $578,785. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,457
Previous 10,230
31.54%
Holding current value
$578,785
Previous $398,000
39.7%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$283 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$197 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$139 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$120 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$112 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.58B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...